Frankel – Chimeric Antigen Receptor T Cells-Charting the Course from Clinical Trials to Commercialization
JCI - HIV-specific CAR T cells return to the clinic
Anti-CD19 CAR T cells potently redirected to kill solid tumor cells | PLOS ONE
Cells | Free Full-Text | CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies
Frontiers | Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
Professor John G Gribben explains why CART-cell therapy has the potential to revolutionise cancer treatment. | Middle East Medical Portal
Treatment of aggressive lymphomas with anti-CD19 CAR T cells | Nature Reviews Clinical Oncology
Tisagenlecleucel (Kymriah) Drug Information
Efficacy and safety of humanized CD19 CAR‑T as a salvage therapy for recurrent CNSL of B‑ALL following murine CD19 CAR‑T cell therapy
FDA Approves Second CAR T-Cell Therapy - NCI
Cells | Free Full-Text | Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR
The CAT's meow: low-affinity CD19 CAR T cells show strong response with low toxicity in pediatric patients with ALL
Direct Delivery of piggyBac CD19 CAR T Cells Has Potent Anti-tumor Activity against ALL Cells in CNS in a Xenograft Mouse Model: Molecular Therapy - Oncolytics
CASI Pharmaceuticals | CNCT19
Chimeric antigen receptor car t cell therapy | solution for detection | Miltenyi | Miltenyi Biotec | Deutschland
CD19-CAR-T Cells | Encyclopedia MDPI
Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis - The Lancet Haematology
The application of CAR-T cell therapy in hematological malignancies: advantages and challenges - ScienceDirect
Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant | Leukemia
Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies | Biomarker Research | Full Text
EHA 2018: competition is heating up in DLBCL for anti-CD19 CAR-T cell therapies - Pharmaceutical Technology
When CAR T cell therapy crashes
In Vitro Characterization of CD19 CAR T Cells Derived by Electroporation of mRNA | MaxCyte
Cancer immunotherapy with CAR-T cells – behold the future | RCP Journals
